Information Provided By: 
Fly News Breaks for June 23, 2017
PTLA
Jun 23, 2017 | 08:47 EDT
After examining 22 cases over the last three years where a PDUFA date for a drug's approval fell on a weekend or holiday, Citi analyst Yigal Nochomovitz found a "strong bias" for the FDA to issue its decision prior to, rather than on or after, the deadline date. Given that the PDUFA date for Portola's betrixaban falls on Saturday, June 24, Nochomovitz said he expects the FDA to issue its decision on betrixaban today, June 23. The analyst, who sees a high probability of approval, keeps a Buy rating on Portola shares.
News For PTLA From the Last 2 Days
There are no results for your query PTLA
